Evidence map›Paper›PMID 40482638›Full record

ArticleNeuron2025

Neurodevelopmental origins of structural and psychomotor defects in CXCR4-linked primary immunodeficiency.

Giulia Demenego, Sara Mancinelli, Antonella Borreca, Rosalba Olga Proce, Vanessa Aragona, Matteo Miotto, Marco Cremonesi, Laura Zucchelli, Irene Corradini, Eugene Kim and 10 more

Abstract read
In one paragraph

Article in Neuron, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Giulia DemenegoDepartment of Biomedical Sciences, Humanitas University, Rozzano, Italy; Neurodevelopmental Biology Laboratory, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Sara MancinelliDepartment of Biomedical Sciences, Humanitas University, Rozzano, Italy; Neurodevelopmental Biology Laboratory, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Antonella BorrecaInstitute of Neuroscience, National Research Council, Rome, Italy; Pharmacology and Brain Pathology Laboratory, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Rosalba Olga ProceNeurodevelopmental Biology Laboratory, IRCCS Humanitas Research Hospital, Rozzano, Italy; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Vanessa AragonaDepartment of Biomedical Sciences, Humanitas University, Rozzano, Italy; Neurodevelopmental Biology Laboratory, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Matteo MiottoNeurodevelopmental Biology Laboratory, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Marco CremonesiAdaptive Immunity Laboratory, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Laura ZucchelliDepartment of Biomedical Sciences, Humanitas University, Rozzano, Italy.
Irene CorradiniPharmacology and Brain Pathology Laboratory, IRCCS Humanitas Research Hospital, Rozzano, Italy; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Eugene KimDepartment of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience King's College, London, UK.
Katarina IlicDepartment of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience King's College, London, UK.
Edoardo FravigaDepartment of Biomedical Sciences, Humanitas University, Rozzano, Italy; Pharmacology and Brain Pathology Laboratory, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Luca PellegrinoDepartment of Biomedical Sciences, Humanitas University, Rozzano, Italy; Applied Physics, Biophysics and Microfluidics Laboratory, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Raffaele BadolatoPediatrics Clinic and Institute for Molecular Medicine A. Nocivelli, Department of Clinical and Experimental Sciences, ASST-Spedali Civili of Brescia, University of Brescia, Brescia, Italy.
Roberto RusconiDepartment of Biomedical Sciences, Humanitas University, Rozzano, Italy; Applied Physics, Biophysics and Microfluidics Laboratory, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Davide PozziDepartment of Biomedical Sciences, Humanitas University, Rozzano, Italy; Pharmacology and Brain Pathology Laboratory, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Marinos KallikourdisDepartment of Biomedical Sciences, Humanitas University, Rozzano, Italy; Adaptive Immunity Laboratory, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Diana CashDepartment of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience King's College, London, UK.
Michela MatteoliDepartment of Biomedical Sciences, Humanitas University, Rozzano, Italy; Pharmacology and Brain Pathology Laboratory, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Simona LodatoDepartment of Biomedical Sciences, Humanitas University, Rozzano, Italy; Neurodevelopmental Biology Laboratory, IRCCS Humanitas Research Hospital, Rozzano, Italy. Electronic address: simona.lodato@hunimed.eu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inborn errors of immunity (IEI), as congenital chronic disorders, are often associated with neurobehavioral symptoms, traditionally considered secondary to patient burden. Their origin, however, has yet to be addressed. Here, we found that IEI-associated genes are expressed in neural lineages during human brain development, and in the absence of immunological challenges, IEI mutations directly impair neurodevelopmental trajectories, leading to psychomotor defects. Warts hypogammaglobulinemia immunodeficiency myelokathexis (WHIM) mice-bearing a mutation causing Cxcr4 hyperactivation-show developmental foliation defects of the cerebellum correlating with sensorimotor and affective dysfunctions, which recapitulate the alterations described in patients. WHIM cerebella single-cell profiling revealed major transcriptional deregulation in granule cell progenitors, whose aberrant proliferation and migration induce foliation and circuit defects. AMD3100 intracerebroventricular injection rescues both morphological and behavioral defects, demonstrating their brain-specific and Cxcr4-dependent origin. Collectively, our findings highlight the relevance of neurodevelopmental implications underlying psychomotor IEI manifestations, broadening our understanding of these conditions beyond immune dysfunctions.

Indexed as

Immunologic Deficiency SyndromesPrimary Immunodeficiency DiseasesPsychomotor DisordersReceptors, CXCR4WartsAnimalsBenzylaminesBrainCerebellumCyclamsFemaleHumansMaleMiceMutationBenzylaminesCXCR4 protein, humanCXCR4 protein, mouseCyclamsplerixaforReceptors, CXCR4cerebellumCXCR4granule cellsimmunodeficiencyinborn errors of immunityneurodevelopmentneuroimmune interactionsplerixaforpsychomotor symptomsWHIM syndrome

Identifiers

PMID40482638
PMCPMC12416883

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.